Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CD44 | P16070 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24332735 | 0.81 | ESR1 (0.41) | ESR1ESR2 | |
| SCHEMBL25210957 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1TSHRPOLBESR1ESR2 | |
| SCHEMBL30429057 | 0.79 | GAA (0.50) | ALDH1A1TP53TSHRESR1ESR2 | |
| SCHEMBL24190794 | 0.79 | GAA (0.50) | ALDH1A1TP53TSHRESR1ESR2 | |
| SCHEMBL26327918 | 0.79 | AR (0.33) | ALDH1A1POLBESR1ESR2GAA | |
| SCHEMBL11052697 | 0.79 | CA1 (0.46) | ALDH1A1CYP3A4ESR1ESR2GAA | |
| SCHEMBL1814835 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL22326124 | 0.77 | CYP3A4 (0.45) | ALDH1A1TDP1TP53CYP3A4TSHR | |
| SCHEMBL28024757 | 0.74 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL25626816 | 0.74 | ESR1 (0.35) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220106444-A1 | Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-04-07 | — | — | US | claimed |
| WO-2020162408-A1 | METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE | セントラル硝子株式会社 | 2020-08-13 | — | — | WO | claimed |
| CN-104829853-A | Polyimide gas separation membrane as well as preparation method and applications thereof | CHINESE ACAD INST CHEMISTRY | 2015-08-12 | — | — | CN | claimed |
| US-12435185-B2 | Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12351685-B2 | Polyamide acid, polyimide, optical film, display device and production methods thereof | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-07-08 | — | — | US | disclosed |
| US-20230323030-A1 | Polyamide, Polyamide-Imide, Derivatives of These, Optical Film, Display Device, and Production Methods Therefor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230323030-A1 | Polyamide, Polyamide-Imide, Derivatives of These, Optical Film, Display Device, and Production Methods Therefor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230323030-A1 | Polyamide, Polyamide-Imide, Derivatives of These, Optical Film, Display Device, and Production Methods Therefor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| WO-2023190187-A1 | MALEIMIDE COMPOUND, MALEAMIC ACID COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, ELECTRONIC DEVICE, METHOD FOR PRODUCING MALEIMIDE COMPOUND AND METHOD FOR PRODUCING MALEAMIC ACID COMPOUND | セントラル硝子株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190187-A1 | MALEIMIDE COMPOUND, MALEAMIC ACID COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, ELECTRONIC DEVICE, METHOD FOR PRODUCING MALEIMIDE COMPOUND AND METHOD FOR PRODUCING MALEAMIC ACID COMPOUND | セントラル硝子株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023182141-A1 | EPOXY COMPOUND, EPOXY RESIN, EPOXY RESIN COMPOSITION, CURED PRODUCT, PREPREG, FIBER-REINFORCED COMPOSITE MATERIAL, PRODUCING METHODS THEREFOR, SEALING MATERIAL, SEMICONDUCTOR DEVICE, METHOD FOR SEALING SEMICONDUCTOR ELEMENT, AND METHOD FOR USING SAME AS SEALING MATERIAL | セントラル硝子株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-4163319-A1 | POLYAMIDE, POLYAMIDE-IMIDE, DERIVATIVES OF THESE, OPTICAL FILM, DISPLAY DEVICE, AND PRODUCTION METHODS THEREFOR | Central Glass Company, Limited (JP) | 2023-04-12 | — | — | EP | disclosed |
| US-20220119595-A1 | Polyamide Acid, Polyimide, Optical Film, Display Device and Production Methods Thereof | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20220119595-A1 | Polyamide Acid, Polyimide, Optical Film, Display Device and Production Methods Thereof | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20220106444-A1 | Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-04-07 | — | — | US | disclosed |
| WO-2020162411-A1 | POLYAMIDE ACID, POLYIMIDE, OPTICAL FILM, DISPLAY DEVICE AND PRODUCTION METHODS OF THOSE | セントラル硝子株式会社 | 2020-08-13 | — | — | WO | disclosed |
| WO-2020162408-A1 | METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE | セントラル硝子株式会社 | 2020-08-13 | — | — | WO | disclosed |
| WO-2020162408-A1 | METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE | セントラル硝子株式会社 | 2020-08-13 | — | — | WO | disclosed |
| CN-104829853-B | A kind of polyimide gas separating film and preparation method and application | 中国科学院化学研究所 | 2017-12-12 | — | — | CN | disclosed |
| CN-104829853-A | Polyimide gas separation membrane as well as preparation method and applications thereof | CHINESE ACAD INST CHEMISTRY | 2015-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106444-A1 | Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane | NAF1, FXR1, AFF1 | ALDH1A1 624/4885TDP1 349/4885TP53 3544/4885 |
| US-12351685-B2 | Polyamide acid, polyimide, optical film, display device and production methods thereof | PUF60, PARG, TET3 | ALDH1A1 3041/4885TDP1 2193/4885TP53 4549/4885 |
| US-12435185-B2 | Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane | NAF1, FXR1, AFF1 | ALDH1A1 624/4885TDP1 349/4885TP53 3544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.